Summary on Metabolomics

Metabolomics captures the downstream chemical outcomes of cellular activity, providing a direct readout of real-time physiological and pathological states. It is a powerful tool for real-time clinical diagnostics, monitoring dynamic physiological responses, personalizing nutrition and therapy, and optimizing biotechnological processes. The future advancement of metabolomics will depend on its integration with emerging technologies and continued innovation in mass spectrometry–based platforms. Combined analytical approaches such as LC–MS (Liquid Chromatography–Mass Spectrometry), GC–MS (Gas Chromatography–Mass Spectrometry), and CE–MS (Capillary Electrophoresis–Mass Spectrometry) will enhance metabolite coverage and improve the resolution of complex metabolic pathways. This will enable deeper insights into disease pathogenesis and support robust applications in early diagnosis, prognosis, and treatment monitoring. However, to realize this potential, significant challenges related to reproducibility and cross-study comparability must be addressed. Variability in analytical methods, sample preparation, and data processing requires a concerted shift toward methodological standardization and the adoption of absolute metabolite quantification to generate robust, platform-independent data. Through these advancements, metabolomics is poised to transform complex biological data into actionable knowledge, driving progress in precision medicine, biotechnology, and our fundamental understanding of health and disease.